SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Business
Valeant CEO Assuages Shareholders, Says Company Will Get Through Troubled Times
December 17, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Novartis AG Fesses Up to Valeant-Like Pharmacy Scheme in $390 Million Settlement
November 23, 2015
 · 
3 min read
Job Trends
Embattled Valeant to Offer Cash and Stock to Keep Anxious U.S. Employees
November 19, 2015
 · 
4 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Female Sex Drug Addyi Not Sprouting Sales for Valeant
November 17, 2015
 · 
3 min read
Deals
Allergan CEO Finds Valeant Business Model Incompatible
November 12, 2015
 · 
3 min read
Business
Valeant CEO Breaks Silence, Shares Goals for Dermatology Business
November 11, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Goldman, Sachs & Co. Forced Valeant CEO to Sell $1.3 Million Shares of Company
November 9, 2015
 · 
4 min read
Business
Questions Swirl About the Future of Valeant CEO Pearson
November 6, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Citron Declines to Publish Additional Negative Valeant Reports, Opts to Send Information to Investigative Reporters Instead
November 3, 2015
 · 
4 min read
Load More
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
 · 
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
 · 
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
 · 
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
 · 
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
 · 
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
 · 
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
 · 
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
 · 
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
 · 
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
 · 
4 min read
Load More